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Abstract
Rat septal cells, induced to enter a terminal differentiation-like state by temperature shift, produce prion protein (PrP) levels
7x higher than their proliferative counterparts. Host PrP accumulates on the plasma membrane, newly elaborated
nanotubes, and cell-to-cell junctions, important conduits for viral spread. To find if elevated PrP increased susceptibility to
FU-CJD infection, we determined agent titers under both proliferating and arresting conditions. A short 5 day arrest and a
prolonged 140 day arrest increased infectivity by 5x and 122x (.2 logs) respectively as compared to proliferating cells. Total
PrP rapidly increased 7x and was even more elevated in proliferating cells that escaped chronic arrest conditions. Amyloid
generating PrP (PrP-res), the ‘‘infectious prion’’ form, present at ,100,000 copies per infectious particle, also increased
proportionately by 140 days. However, when these highly infectious cells were switched back to proliferative conditions for
60 days, abundant PrP-res continued to be generated even though 4 logs of titer was lost. An identical 4 log loss was found
with maximal PrP and PrP-res production in parallel cells under arresting conditions. While host PrP is essential for TSE agent
spread and replication, excessive production of all forms of PrP can be inappropriately perpetuated by living cells, even after
the initiating infectious agent is eliminated. Host PrP changes can start as a protective innate immune response that
ultimately escapes control. A subset of other neurodegenerative and amyloid diseases, including non-transmissible AD, may
be initiated by environmental infectious agents that are no longer present.
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Introduction
It is often stated that the normal host prion protein (PrP)
converts itself into an infectious, protease resistant form (PrP-res)
that causes diverse transmissible encephalopathies (TSEs). TSEs
include human Creutzfeldt-Jakob Disease (CJD) and kuru, sheep
scrapie, and epidemic Bovine Spongiform Encephalopathy (BSE).
The recent outbreak of a virulent strain of epidemic BSE has now
been largely eradicated with the removal of infected meat and
livestock. While the infectious protein or prion concept has
garnered a large following, i) geographically specific environmen-
tal origins of different TSEs [1,2,3], ii) the classic viral-like spread
of these agents through the lymphoreticular system, white blood
cells and dendritic cells to the brain [4,5], iii) early innate immune
responses of the host that signify host recognition of a foreign
infectious agent [6], iv) abundant agent replication before PrP-res
becomes detectable [7,8], and v) the lack of any consistent strain-
specific forms of ‘‘infectious’’ PrP [1,9] all pose fundamental
problems for the prion hypothesis. For simplicity, we here consider
prions as their originally defined PrP
sc form (identical to proteinase
K resistant PrP-res) [10].
A variety of independent experimental approaches have been
used to determine the quantitative relationship of PrP-res to the
number (titer) of infectious particles. While PrP-res is a valuable
diagnostic marker for TSE disease, analytic experiments have
repeatedly shown that PrP and PrP-res quantities are poor
predictors of infectious titer. For example, infectious ,25nm
virus-like particles reproducibly separate from the majority of PrP
and PrP-res during centrifugation (reviewed in [11]), and test-tube
PrP misfolding-conversion ‘‘PMCA’’ assays typically show enor-
mous amounts of de novo PrP-res can be generated with low or
absent infectivity (e.g., [12,13]). PrP-res itself appears to be
insufficient for infection and most PMCA reactions need to be
repeatedly primed with complex brain homogenates. Cell free
replication does not rule out a viral structure because plant and
even mammalian viruses such as poliovirus [14] can make
substantial infectious virus in cell free systems; presumably even
more virus would be produced if the needed cell free components
for viral synthesis or assembly were similarly replenished. The
reported generation of infectivity from recombinant PrP alone
[15] has not been reproduced, nor has anyone independently
repeated the high infectivity from recombinant PrP and lipids
without the borrowed and pooled infectious ‘‘seed’’ [16].
Furthermore, recent critical experiments have demonstrated
inadvertent contamination underlying ‘‘spontaneous conversion’’
into an infectious form [17].
To account for the discrepancy between PrP-res and infectious
titer, it is now postulated that a minor, and still uncharacterized
protease-sensitive form of PrP, is the real infectious entity [18,19].
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before and after proteolytic digestion for all detectable forms of
PrP as well as for infectivity. Remarkably, virtually complete
digestion of all forms of PrP in high titer FU-CJD infected brain
homogenates did not reduce the infectious titer [20]. While it can
be argued that only a minute number of invisible prion molecules
constitute the infectious entity, it is more likely that PrP is not the
infectious agent, but instead, the essential host receptor for a
foreign infectious particle that contains a nucleic acid genome.
Indeed, circular DNAs with long sequence stretches not in the
database have been identified in a variety of infectious prepara-
tions [21]. The idea that PrP is a TSE virus receptor readily
accounts for the failure of TSE agents to infect PrP knockout mice.
Although the normal function(s) of PrP is not entirely clear, cell
and developmental biology experiments also show that PrP
normally functions as a membrane receptor, one that additionally
may act as a crucial facilitator for transmission of infectious TSE
particles from cell-to-cell [22]. A dramatic rise in PrP occurs when
embryonic rat neural cells are induced to differentiate by
proliferative arrest. Concomitantly, these arrested cells develop
extensive PrP-rich cell-to-cell junctions, in addition to a network of
connecting nanotubes, structures known to transport and spread
viruses throughout a cell population (reviewed in [22]). On the
other hand, PrP can also be part of an innate immune defense
mechanism. A rapid PrP-res rise in response to infection by the
kuru agent in the GT1 neural cell line appears to prohibit
accumulation of infectious particles. In contrast, very high FU-
CJD agent titers are found in GT1 cells when PrP-res responses
are delayed, suggesting PrP can help to retard or diminish
infection [23]. In accord with this, PrP has antiviral properties and
reduces HIV expression [24]. PrP also displays wider antimicro-
bial activities [25] that are most consistent with innate immune
anti-infective functions.
To further test the TSE-agent-PrP dependent receptor concept,
and clarify if PrP has a role in host defense, we evaluated the
temporal relationship between agent titers and PrP in both
proliferating low PrP, and arrested high PrP rat neural progenitor
septal (SEP) cells. SEP cells carry the temperature sensitive SV-
40 T antigen that provides for proliferative arrest at the physiolog-
ical temperature of 37.5uC in 2% serum; proliferative SEP cells are
kept at 33uC in 10% serum. For infection, we used rat brain
homogenates carrying the Japanese human FU-CJD agent, a strain
that is more virulent than the classic sporadic CJD (sCJD) agent
found in the USA and Europe [2,23]. By the 3
rd serial rat passage
(p3), the more virulent FU-CJD agent achieved an incubation time
in rats that was ,100 days shorter than in sCJD rats ([8] and LM
unpublisheddata). Interestingly, as found with other TSE agents
transmitted to heterologous species, the rat-propagated FU-CJD
agent maintained its ability to infect murine GT1 cells with the
same characteristics as the FU-CJD propagated in mice. Thus
GT1 cell assays yielded reliable titrations of FU-CJD particles in
SEP cells.
We here show that 1) a short 5 day induction of high PrP by
SEP cell arrest leads to a small 5x increase in infectivity over
parallel proliferating low PrP SEP cells; 2) cells chronically
maintained under arresting conditions for .100 days show a
dramatic .2 log increase in titer compared to proliferating cells,
and 3) infected chronically arrested cells, when returned to a
proliferative state, maintain very high levels of both PrP and PrP-
res even though almost all infectious particles have been
eliminated. The large amounts of residual PrP-res that continue
to be produced in such ‘‘self-cured’’ cells provides a living cell
parallel to the generation of non-infectious PrP-res in PMCA test-
tube assays. Living cells therefore can independently perpetuate a
cascade of PrP amyloid without infection, and with no
requirement for inflammatory cells. Although PrP aggregation
and amyloid formation initially may be part of a protective, innate
cell response to infectious particle binding, PrP misfolding appears
to develop progressively, and then continues to be formed as an
inappropriate end-stage reactive cascade, much like that seen in
auto-immunity. These findings raise an important new perspective
on the origin and development of more common neurodegener-
ative amyloid diseases, including non-transmissible Alzheimer’s
Disease (AD) [26]. A subset of AD brains may have amyloid and
other protein aggregates caused or initiated by hidden and/or
previously cured viral infections [27]. Indeed, neurodegenerative
amyloids, including PrP-res, are typically late-stage pathologic
products that can be triggered by one or more environmental
factors.
Materials and Methods
Infectious Material and Established Cell Lines
All animal procedures were carried out in strict accordance with
the recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health (NIH) and
Yale Animal Care approved protocols and are in compliance with
all ethical standards. Yale is an Association for Assessment of
Laboratory Animal Care (AALAC)-accredited facility and the
protocol used was approved by the Yale Institutional Animal Care
and Use Committee (IACUC protocol #2011–10020). All
procedures were done under approved anesthesia under best
practice at the time when collected here and as published [8,9],
and all efforts were made to minimize distress. The established cell
lines and sources have previously been reported for all lines used,
including embryonic rat septal (SEP) cells originally started by B.
Wainer [28] and the murine hypothalamic GT1 cell line of
Nishida [2,9].
Conditions for Infection, Proliferation and Arrest
Low passage rat neural progenitor SEP cells (subclone e422, a
gift of B. Wainer) as published [28], were maintained and assayed
as previously described under verified proliferative and stationary
conditions [22]. Briefly, proliferating cells were maintained at
33uC with 10% fetal calf serum in DMEM, whereas stationary
arrest was induced by elevating the temperature to 37.5uC and
reducing serum to 2%. Proliferating cells were split 1:4 every
4 days. Stationary cells were 90% arrested by day 2, as previously
shown by uptake of BrdU with a corresponding decrease in SV40
T antigen; concomitantly, there was a rapid 5–10 fold increase
in prion protein (PrP) detected on Western blots, with obvious
PrP accumulations at the cell surface [22]. Stationary cells were
initially refed in situ, and then split at 1:2 every 7 days up to
p11 (day 81). After this, cells under stationary conditions could
be split at 1:4 every 4 days because cells not completely arrested
had a growth advantage that allowed them to predominate. As
graphically detailed, a short 5 day arrest of infected proliferating
cells (Fig. 1A) was compared to long term infection under
continuous arresting conditions for 140 days (Fig. 1B). Chron-
ically ‘‘arrested’’ cells were also compared for 60 additional days
to parallel cells returned to proliferative conditions at 140 days
(Fig. 1C).
Infection of immortalized SEP cells were performed as
previously for other cell lines here [9] with minor modifications.
Briefly, before infection, e5 cells were plated in each well of a 6-
well chamber plate. At day 3, cells were exposed to infected FU-
CJD rat brain (10 ml of a 10% brain homogenate in 2 ml
medium). Two days after application of infectious material, cells
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and PrP-res) as previously demonstrated [29], and fresh medium
was added for an additional 3 days. For proliferating cells, the first
post-infection (p.i.) passage (p1) split was at 1:4. Three different
frozen FU-CJD infected rat brain samples (from rat serial passages
3 and 4) all gave positive de novo PrP-res signals after SEP cell
infection. Control SEP cells analyzed before infection at day 0
showed no PrP-res. For infection of arrested cells, the same basic
procedure was used, but the first day after seeding at 33uC-10%
serum, cells were transferred to 37.5uC-2% serum for 2 days to
induce arrest with high PrP during infection. These stationary cells
were then exposed to FU-CJD rat brain homogenate for 4 days
before being washed, refed in situ, and then split at 1:2 every
7 days until p11 as detailed above.
Protein and Infectivity Assays
Standard Western blotting with quantitative chemiluminescent
detection of signals was done using the primary commercial
antibodies for PrP, tubulin and ß-actin as previously detailed
[9,22]. The tissue culture infectious dose in each SEP cell
homogenate was assayed by exposing duplicate wells seeded with
murine GT1 indicator cells to a series of SEP homogenate
dilutions. Dilutions of FU-CJD infected rat SEP cells showed the
same strain-specific progressive induction of PrP-res as FU-CJD
infected mouse brain and murine GT1 hypothalamic cells [23].
Serial dilution assays also showed that FU-CJD infected SEP rat
cells were capable of producing very high titers of infectious
particles. As many as 5 TCID per cell could be produced under
arresting conditions, (i.e., 5e9 TCID per gram brain with e9 cells).
This is comparable to the high titer of FU-CJD GT1 murine cells
(3 TCID per cell). The TCID in rat SEP cells was accordingly
calculated using the previously defined standard FU-CJD agent-
specific curves [23]. For example, at p7 the TCID =71.89*
e
(023436*X), and at p5 TCID=10.781*e
(025224*X); the slopes of
both lines are the same at different passages but the infectivity is
less when the same %PrP-res requires more passages. Average
%PrP-res of duplicates were used for all TCID determinations,
and corresponded to plots shown previously for each FU-CJD
passage [23]. For reference, tissue culture infectious doses (TCID)
are ,2–3 fold less than determined in animals by LD50, probably
because mice are followed for a much longer time, up to 500 days
p.i. for end-points.
Results
If host PrP is a required receptor for TSE agents, then
increasing the level of PrP should increase both susceptibility to
infection and the infectious titer. In Tga20 mice with 8x the levels
of PrP, the incubation time of CJD and scrapie agents is reduced
as compared to wt mice with 1x PrP [1,3,9,30]. This shows PrP
enhances susceptibility to TSE infectious agents. On the other
hand, the final brain titer in Tga20 mice is not higher than in wt
mice [30]. Rat SEP cell cultures that will produce high PrP levels
under arresting conditions (37.5uC-2% serum) offered another
opportunity to explore the relationship of titer to PrP and PrP-res
in a highly controlled biological system. Uninfected SEP cells
rapidly transition into a stationary non-dividing state that
resembles terminal neural differentiation, and they concomitantly
express ,7x levels of PrP. When uninfected control SEP cells are
maintained long term at 37.5uC-2% serum they continue to
produce 5–8x levels of PrP, and when switched to standard
proliferative conditions (33uC-10% serum) they immediately revert
to 1x PrP levels [22].
Fig. 1 shows the basic design of experiments where infectivity
and both PrP and PrP-res were analyzed. In the first strategy
(Fig. 1A) proliferating SEP cells were exposed to FU-CJD brain
homogenates, grown and split for 15 passages (day 74 p.i.) and
then switched to the arresting conditions of 37.5uC-2% serum for
5 days. As indicated, proliferating counterparts (33uC-10% serum)
were compared in parallel at the same passage. The extended
maintenance of proliferating infected SEP cells amounted to a .1
in a trillion dilution of p1 cells under standard 1:4 dilutions at each
passage. Tissue culture infectious dose assays (TCID) revealed a
stable and continuous baseline of productive infection in
proliferating SEP cells (0.43 TCID per 10 cells). Acutely arrested
SEP cells demonstrated a 5x increase in FU-CJD agent as
compared to their proliferating counterparts. As indicated in
Fig. 1A, these stationary cells contained 2.3 TCID per 10 cells.
This small increase was reproduced with several different FU-CJD
Figure 1. Outline of the three temperature shift experiments
with days post-infection (p.i.) sample points analyzed for PrP
and PrP-res. The * indicates tissue culture infectious dose (TCID)
determined at the indicated time points. A) infected proliferating SEP
cells at 33uC-10% serum with parallel cells arrested at 37.5uC-2% serum
for 5 days; the latter cells contained 5x more infectious particles. B) cells
infected at 37.5uC-2% serum (p0) and maintained under arresting
conditions for a total of 140 days. Cells at 140 days contained .2 logs
more infectivity than control proliferating cells in A. C) comparison of
parallel aliquots of high titer cells returned to proliferative conditions, or
maintained under arresting conditions until 200 days. TCID determina-
tions were done for both sets at 200 days, and both showed an ,4 logs
(5,000 fold) reduction in infectious particles per cell as compared to
140 day precursor cells. For examples of the TCID assay see Fig. 4.
doi:10.1371/journal.pone.0035471.g001
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tion of infectious particles in non-dividing cells. Since the effective
doubling time of the FU-CJD agent in monotypic cells is 1 day
[23], one would predict an 8x increase in titer during the 3 days
after SEP cells stopped dividing, in reasonable accord with the 5x
increase found. Arrested cells were healthy and comparable to
proliferating infected and uninfected controls.
To find if arrested SEP cells with high PrP are more susceptible
to infection than proliferating cells, and if higher levels of infection
can be propagated under chronic arrest conditions, we used the
strategy shown in Fig. 1B. Previous control experiments showed
that uninfected SEP cells grown under arresting conditions
maintained high PrP levels long term, even after the small
population of dividing cells began to dominate. FU-CJD infected
cells arrested for a prolonged time period also revealed that
selected cells progressively escaped arrest. Infected arrested cells
could be split at only 1:2 for 11 passages, but after this could be
split at 1:4 despite continued maintenance under arresting
conditions. This is not surprising because SEP cell arrest is not
absolute, and 5–10% show nuclear DNA synthesis with a 2 day
arrest [22]. SEP cells were maintained at 37.5uC-2% serum for a
total of 140 days (p19), before collecting cells for TCID
determinations. By 140 days p.i. the total original infected cells
that remained accounted for only 1 in a population of a million.
These cells that escaped arrest showed no toxic or morphological
changes as compared to controls. However, they contained
49 TCID per 10 cells, a huge 122x increase in infectivity over
proliferating cells (Fig. 1A). Additionally, cells under long-term
arresting conditions showed a significant increase in infectivity
compared to 5-day arrested cells (21.3x). Thus the long term
increase of infectious particles was clearly not due to a simple
accumulation of particles in non-dividing SEP cells.
It was relevant to find if infectivity is reduced after reversal of
long-term arresting conditions. Fig. 1C shows this third strategy.
Because uninfected SEP cells with high PrP rapidly reverted to a
low PrP state when switched to proliferative conditions, we
expected the highly infectious SEP cells here would show the same
immediate reversion to a low PrP state. A concomitant reduction
in infectious particles to baseline levels would also be expected.
When long-term arrested cells were returned to proliferative
conditions at day 135 (p18), and then maintained until day
200 p.i. (p28), they displayed markedly reduced infectivity, with
only 1 TCID per 1,000 cells, considerably less (1/40
th) than the
infectivity of infected basal proliferating cells (see Fig. 1A).
Unexpectedly, arrested SEP cells maintained in parallel for
200 days (to p28) at 37uC-2% serum also revealed an identical
negligible number of infectious particles even though they
appeared indistinguishable from high titer cells. Indeed, these
Figure 2. Total PrP (light gray bars) and %PrP-res of the total
PrP (dark gray bars) at progressive times corresponding to
outlined experiments A, B, and C in Fig. 1. Note the TCID scale
change in each graph. Prior to infection (p0), proliferating SEP cells have
a baseline of 1x total PrP and no detectable PrP-res. A) Post-infection
with FU-CJD, proliferating cells showed continuous production of low
amounts of PrP-res (1.2% of total PrP) up to 125 days; these
proliferating infectious cells were compared at 81 days with parallel
SEP cells that were switched in parallel for 5 days to arresting
conditions. PrP-res was 0.6%, and total PrP had increased 7-fold in
5 days; previous 5 day arrest of uninfected SEP cells showed the same
7-fold rise in total PrP, but no PrP-res [22]. B) With long-term arresting
conditions, total PrP remains very elevated (.10x of proliferating cells);
the single 125 day sample with a lower total PrP contained a relatively
high %PrP-res, consistent with breakdown by cellular proteases; these
PrP changes were not a consequence of long term arrest because the
subsequent 140 day arrested cells again contained markedly elevated
PrP. Note the slowly progressive increase in %PrP-res and the
corresponding high 5 TCID/cell after 140 days of arrest. C). With
continued arrest to 200 days, total PrP was again very elevated (13.3x)
and PrP-res was even higher than at 140 days. Unexpectedly these cells
contained only 1 TCID/1,000 cells, i.e., almost 4 logs of infectious
particles were eliminated. FU-CJD infected cells switched for 60 days to
proliferative conditions also continued to produce high PrP, unlike
previously documented uninfected controls [22], and also continued to
convert PrP into very high levels of PrP-res (40% of total PrP). TCID are
shown by filled circles (note change in scale between A,B and C).
doi:10.1371/journal.pone.0035471.g002
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140 day precursors (compare Fig. 1B). Presumably, according to
the prion hypothesis, the released proliferating SEP cells, as well as
those maintained under arresting conditions, should concomitant-
ly show negligible PrP and/or PrP-res.
Fig. 2 shows the total PrP and %PrP-res during the three
temperature-serum shift experiments outlined above. In Fig. 2A,
no PrP-res was detectable in proliferating cells (day 0, p0) prior to
infection. After infection, total PrP in the proliferating cells did not
change, and only a small amount of PrP-res (1.2% of total PrP)
was detectable for up to 81 days p.i. With a short 5 day arrest at
37.5uC-2% serum, infected SEP cells, as previous control
uninfected cells [22], rapidly displayed a 7 fold increase in total
PrP, 0.6% of which is PrP-res. Western blot primary data for this
p16 time point is shown in Fig. 3A with tubulin used to normalize
protein loads in each lane. While the %PrP-res did not correlate
with the acute 5x increase in TCID at 5 days (solid circles), it did
show a reasonable correlation to the relative increase in the
number of PrP-res molecules compared to proliferating controls.
There was a 7x increase in total PrP and a 3.5 fold relative
increase in PrP-res molecules (see Fig. 3A, PrP-res #). This
number is biologically equivalent to a 5x increase in infectious
particles and represents an increase of ,100,000 PrP-res
molecules per TCID. Note the 13kd band seen in FU-CJD
infected SEP cells, an agent specific marker that is induced only by
Asiatic CJD isolates propagated in cell cultures [3].
Long-term propagation of FU-CJD SEP cells under arresting
conditions documents the continuous maintenance of high PrP
levels. Cells were sampled representatively between 27 and
140 days p.i. as shown in the bar graph of Fig. 2B. During this
extended arrest, the total PrP in FU-CJD infected SEP cells was,
with one exception, 10–16x higher than in parallel infected
proliferating cells. Interestingly, uninfected controls during long
term arrest showed an average of 6.8x (+0.7 SEM) total PrP
whereas FU-CJD infected cells, even with the inclusion of the
single low outlier, had a higher average total PrP of 11x
(+1.4 SEM). This was statistically significant by student’s t-test,
with a mean difference of 4.1x (P=0.03). It thus appears that
chronic TSE infection of neural SEP cells, without the
contribution of inflammatory or other cell types, is capable of
inducing a distinct PrP response that exceeds that found in
standard differentiation arrest.
Unlike test-tube PMCA experiments where PrP rapidly converts
to PrP-res, the PrP-res in cells accumulated slowly and
progressively. PrP-res rose from 0.7% PrP-res at day 27 (p3) to
18–25% by 125–140 days. This slow accumulation of PrP-res
could suggest PrP-res was elaborated as part of a defense
mechanism against increasing accumulation of infectious particles.
At 140 days, the %PrP-res was 18x greater than in proliferating
SEP cells that contained 2 logs less infectivity. However, because
the total PrP was 11x greater than in the FU-CJD proliferating
cells, there was a 158 fold increase in the relative number of PrP-
res molecules. Thus this example does not distinguish PrP-res from
infectious titers; the 158x proportional increase in PrP-res
molecules fairly reflects the 122x increase in titer. Fig. 3B shows
the Western blot of this 140 day (p19) sample with very high
infectivity (5 TCID/cell). The more rapid proliferation of arrested
SEP cells after p11, equivalent to a SEP cell dilution of ,100,000,
clearly did not inhibit the enormously increased production of
infectious particles, nor did it reduce the total PrP elaborated. This
titer increase further indicates an enhanced cell-to cell transit of
infectious particles that is facilitated by high plasma membrane
PrP, and/or a progressive replication of infectious particles
boosted by continuous high PrP availability. Note again the
induced 13kd PrP band that is agent-specific and has not changed
with 140 days of replication in SEP cells.
While an increase in total number of PrP-res molecules showed
a reasonable correlation with infectivity in the first two
experiments, the third strategy uncovered a profound dissociation.
This experiment demonstrated that 1) changes in PrP are part of
an accelerating host response to infection that could not be shut
off, and 2) markedly abnormal PrP-res accumulations were
maintained after virtually all infectious particles were eliminated.
Previous independent experiments have shown that all forms of
PrP can be destroyed without loss of infectivity [20], and that
dendritic-like myeloid microglial cells without detectable PrP-res
are highly infectious [31]. However, abundant production of PrP-
res in a living cell without significant infectivity has not been
reported previously. This is important because PrP-res is often
considered synonymous with infectious titers. The following data
underscore PrP and PrP-res changes that are part of a pathological
host response to infection rather than the causative infectious
agent.
Figure 3. Representative Western blots of PrP and PrP-res at
the time of infectivity assay in outlined experiments A, B, and
C. Note the unchanging 13kd band of PrP-res that is a unique
characteristic of Asiatic FU-CJD agent strain in all blots, including the
200 day (p28) samples. A) At p16, FU-CJD infected proliferating cells at
33uC-10% serum have baseline (1x) low amounts of total PrP. Abnormal
PrP-res was visible only on longer exposures and accounted for 1.2% of
total PrP in these proliferating cells. With a short 5 day arrest, the total
PrP rose 7-fold, with 0.6% PrP-res as indicated under each lane. The
relative increase in PrP-res molecules (PrP-res #) is also shown in
comparison to proliferating cells. Tubulin was used to normalize loads,
and as shown, was equivalent in both undigested samples. The tubulin
signal was abolished by PK treatment for PrP-res. B) shows high PrP and
PrP-res after continuous long-term arresting conditions (p19 in 37.5uC-
2% serum) and is also indicated quantitatively under the lanes. C) Long-
term arrested cells switched to proliferative conditions, as well as those
continued in parallel for 60 days (to p28) in arresting conditions, both
display elevated PrP and PrP-res as indicated. The relative number of
PrP-res molecules was even higher than in the precursor 140 day cells
with 4 logs more infectivity. Molecular size markers indicated by dots.
doi:10.1371/journal.pone.0035471.g003
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135 days (the same as those producing the very high titer of
5 TCID/cell at p19, only 5 days later) were used for further
passages. Half of these SEP cells were maintained under arresting
conditions for 10 additional passages until day 200 (p28). The
other half was switched to proliferative conditions and grown in
parallel from p19 to p28 as diagrammed in Fig. 1C. The cell
dilution between p19 and p28 was 3 million, and thus the titer of
the released proliferating cells should be significantly reduced.
However, as noted above, the titer in these cells was even lower
(1 TCID/1,000 cells) than in proliferating controls. According to
the prion concept, one would also expect the relative number of
PrP-res molecules to be reduced to 0.0025x of the baseline
proliferating controls. As shown in Fig. 2C (bars under 33uC) the
%PrP-res at p28 still remained markedly elevated and accounted
for 41% of the total PrP. Moreover, the total PrP remained much
higher than seen in either uninfected controls or in infected
proliferating cells (compare 2A and 2C). As documented in the
corresponding Fig. 3C Western blot, the total PrP was only slightly
reduced, and remained 7.3x the normal proliferative levels even
60 days after release in 33uC-10% serum. The number of PrP-res
molecules in these cells with negligible infectivity, moreover, was
1.6 fold higher than found in their high titer 140 day predecessors.
Additionally, the relative number of PrP-res molecules was also
250 fold greater than the more infectious proliferative cells at p16
(compare Fig. 3A and 3C lanes at 33uC). Notably, there was no
evidence of any change in the FU-CJD agent strain from PrP and
PrP-res characteristics; The FU-CJD strain, as does another
Asiatic isolate (YAM), still induced the strain specific 13kd PrP-res
band at 200 days. Clearly, infection with the FU-CJD agent can
set off a cascade of PrP changes that once established, can not be
readily reversed by either environmental conditions, or even by
the extraordinary elimination of ,4 logs of infectivity.
This concept was further extended by the analysis of cells
maintained under arresting conditions from 140 to 200 days. As
shown in Fig. 2C cells at 200 days (p28) appeared indistinguish-
able from p19 cells at 140 days with respect to both total PrP and
PrP-res, banding patterns, and morphological and growth
characteristics. Total PrP remained elevated at 13.3x, an even
higher level than seen in the highly infectious cells at day 140. PrP-
res additionally became even more abnormally elevated and
accounted for 26.6% of the total PrP. The evidence for this is
detailed in the corresponding Western blot lanes of Fig. 3C. With
a relative PrP-res number of 250, regardless of the form of PrP,
they should have equal or higher levels of infectivity than their
140 day precursors. Yet the titer was reduced by ,4 logs, an
identical loss of infectivity as their parallel counterparts switched to
proliferative conditions. This finding cannot be explained by a
simple retention of cytoplasmic PrP-res from day 140 because the
9 additional 1:4 cell splits between 140–200 days should also have
diluted PrP-res by 3 million fold to undetectable amounts. Again,
these cells continued to produce abnormal PrP-res aggregates
completely out of proportion to their negligible infectivity. This
continuous production of PrP-res underscores a biological host cell
reaction that may have started as a protective response, but has
escaped control.
Fig. 4 shows representative TCID assays of SEP cell
homogenates applied to indicator GT1 cells. In these assays,
serial dilutions of FU-CJD SEP cells at known inputs or cell
equivalents (CE) were applied to GT1 target cells. The time
(passages) required to elicit a PrP-res response to the FU-CJD
agent was analyzed. High titer samples elicit a PrP-res response at
early passages whereas low titer cells need a greater CE input to
induce the same level of PrP-res accumulation in GT1 indicator
cells. After a short 5 day arrest (Fig. 4A), it required 7 passages of
GT1 cells, and an input of 3e3 CE of infected SEP cells to detect a
substantial PrP-res response. These 5 day arrested SEP cells (37–
2% lanes) elicited more PrP-res in the indicator GT1 cells than
their 33–10% SEP counterparts, equivalent to a small but
reproducible 5x increase in titer. Fig. 4B shows that application
of 10-fold fewer SEP cells (only 3e2 CE) gave a strong PrP-res
response after only 5 GT1 passages, equivalent to 5 TCID per cell.
In contrast, 1,000 fold more SEP cells (3e5 CE) collected at
200 days were required to produce a lower PrP-res signal, even
after 7 passages (data not shown).
Discussion
FU-CJD infection of living SEP cells provides insight into innate
host cell responses that have been difficult to sort out in animal
models with complex and multiple cell type reactive changes. The
cell biology of infection and control are not operative and cannot
be analyzed in test tube reconstitution experiments such as
PMCA. The production of extremely high levels of FU-CJD
infectivity in SEP cells with ,10x normal levels of PrP was
unexpected because Tga20 mice with comparably high PrP levels
have not shown increased titers compared to wt mice with 1x PrP;
this is true for diverse agents including Chandler (RML) scrapie,
FU-CJD, and kuru agents in Tga20 mice [3,23,30]. On the other
hand, both SEP cells and Tga20 mice show high PrP facilitates
Figure 4. Examples of infectivity assay with relative TCID per
cell determined by serial SEP cell dilutions. CE are the number of
cell equivalents applied to target GT1 indicator cells, with the %PrP-res
and corresponding TCID noted below the sample lanes. In cells from
experiment A, an input of 3e3 SEP cells and 7 passages were required to
elicit substantial PrP-res production in GT1 indicator cells. The PrP-res in
the 5 day arrested cells is higher than in the proliferative cells, with a
corresponding 5 fold increase in infectious particles. In contrast to
experiment A, 10-fold fewer (3e2) chronically arrested SEP cells
(140 days, experiment B) elicited a substantial PrP-res response much
earlier, at assay p5. CE dilutions of the rat passaged FU-CJD agent again
showed the same FU-CJD specific 13kd band in murine GT1 cells
despite passaging in rats. Moreover, the strain-specific replication curve
was identical to the FU-CJD agent propagated in mice, i.e., this strain is
very stable and showed no detectable changes even though species-
specific host responses to this agent are quite distinct in terms of
incubation time (120 days in mice versus 222 days in rats) and
neuropathology (LM, unpublished data).
doi:10.1371/journal.pone.0035471.g004
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rapid progression to terminal disease, with relatively short
incubation times as compared to wt mice. Similarly, the short
5 day SEP cell arrest with elevation of PrP led to an increase of the
FU-CJD infectious agent close to the predicted level based on the
FU-CJD doubling time. This data is in keeping with PrP as a
receptor that binds to and facilitates the entry and reproduction of
the TSE infectious particle. In mice, high levels of infectious
particles will produce clinical signs of disease, including host
astrocytic and microglial responses that can be destructive and
lead to death [8,32]. Even higher levels of agent did not kill the
SEP cells here, possibly because they are not subject to destructive
cellular elements. SEP cells maintained for 140 days under
arresting conditions continued to produce infectious particles
and high PrP levels even though they escaped arresting conditions
and proliferated at the same rate as their untreated counterparts.
Remarkably, titers of these proliferating FU-CJD infected, high
PrP SEP cells were ,2 logs greater than found in RML scrapie
brain, i.e., 9.3 versus 7.3 logs per gram (e9 cells). This difference
may, at least in part, be due to host responses to the infectious
agent before PrP-res is detectable. During the initial phase of in vivo
infection, non-PrP host responses clearly recognize the infectious
agent [6]. Moreover, agent doubling time studies show that it can
take as much as 22x longer to accumulate the same number of
infectious particles in a mouse brain as compared to cultured
monotypic cells [23]. This emphasizes host recognition of and
defense against an invading foreign TSE agent.
SEP cells also revealed a proportional and progressive rise in the
relative number of PrP-res molecules that accompanied titer
increases in 2 of the 3 experiments. The meaning of this PrP-res
accumulation is not entirely clear because in absolute terms PrP-
res molecules were present at .100,000 per infectious particle.
The %PrP-res rose progressively from 0.6% to .20% of total PrP
in cells kept for 140 days under arresting conditions. On the other
hand, in Tga20 mice the number of PrP-res molecules never
exceeded the numbers found in wt mice, i.e., there is a much lower
%PrP-res in high PrP Tga20 mice than in wt mice. In contrast to
infected Tga20 mice where baseline PrP is not increased, total PrP
was significantly higher in infected versus uninfected SEP cells.
Continuous production of higher PrP was maintained under
prolonged arrest. This indicated that FU-CJD infection itself can
induce the host to synthesize additional PrP as part of a protective
response. Since increased total PrP was not seen in proliferating
cells with low infectivity, relatively high levels of infectivity appear
to be required to enhance PrP production, an observation in
keeping with a protective role for PrP. A protective role for PrP
has also been noted in various types of infection [24,25], and
remarkably, is also critical for subduing experimental colitis and
autoimmune destructive brain changes in experimental allergic
encephalitis [33,34]. The data here supports dual agent receptor
and protective functions for PrP. Although PrP appears to be the
essential host molecule for agent binding and cell-to-cell spread,
PrP, as well as its PrP-res form, can also be crucial for arresting
agent production [23], and for eliminating infectious particles as
demonstrated here. The binding of infectious TSE agent particles
to PrP is a double-edged sword.
The very prolonged 200 day culture studies further support a
role for PrP in innate defense mechanisms. Most notably, the
continued production of elevated levels of both PrP and PrP-res
ultimately led to the elimination of 4 logs of infectivity, with even
fewer infectious particles than in baseline proliferative SEP cells. A
loss of titer was expected in the cells returned to proliferative
conditions. However, the continued production of clearly
abnormal 5x levels of PrP was completely unexpected because1x
baseline PrP was immediately restored in chronically arrested
uninfected controls [22]. Even more surprising was the continued
enormous production of PrP-res molecules (40% of the total PrP)
in these ‘‘cured’’ cells. PrP-res continued to ‘‘be converted’’ and to
accumulate even though PrP-res should have been diluted out a
million fold during the 10 passages prior to assay. The intracellular
mechanisms underlying this continued accumulation are not
known, but could involve propagated seeded misfolding. While
one cannot exclude additional SEP cell responses that ultimately
led to the elimination of infectious particles between 140–
200 days, PrP-res conversion appears to be involved in this
process, especially because it continued unabated and dispropor-
tionately with respect to the negligible residue of infectious
particles.
A dramatic agent strain change, rather than one or more host
cell changes, is unlikely to account for the relatively rapid 60 day
loss of infectious particles, especially when compared to the high
agent accumulation during the first 140 days. Firstly, by 140 days
there was very high multiplicity of infection, and homogeneous
changes to the agent would have to affect virtually all of these
particles in many cells. Notably, high dilution agent cloning in
multiple species is required to achieve any substantial permanent
strain change [reviewed in 2,21,23], and no cell culture strain
change has shown either reproducible or comparable stable agent
changes in serial animal passages, species susceptibility, and
regional neuropathology. Second, there was no evidence of a
change in PrP and PrP-res banding patterns that would denote a
new variation in agent binding to PrP or strain. Indeed, the FU-
CJD agent shows a geographic and strain specific characteristic
13kd band in GT1 cells that distinguishes it from non-Asiatic CJD
strains and sheep scrapie strains [3,9]. This same band was present
in all the infected samples, including 200 day SEP cells with
negligible infectivity. Third, the FU-CJD agent has been passaged
over 30 times in mice and has exhibited no change in its ability to
infect murine cells here after rat passages; a change after only
60 days in culture would, moreover, contrast with the lack of agent
change by culture for much longer periods of .1 year [9]. Finally,
even the highly cloned and passaged 263 K agent, selected for its
inability to re-infect mice, does not completely lose its ability to
permanently infect mice, murine cells and even Tga20 high
murine PrP mice [3].
While the reasons for agent elimination by SEP cells are not
known, and are of particular interest in the context of innovative
therapeutic approaches to TSEs, the continued high production of
both PrP and PrP-res under chronic arresting conditions
implicates a self-perpetuating and escaped innate immune
mechanism. Arrested cells at 200 days, with even higher PrP
and PrP-res than their 140 day precursors, should have continued
to produce high levels of infectivity. But these selected dividing
cells also eliminated virtually all of their infectious particles, again
suggesting that PrP-res is part of a host defense response that can
become inappropriate, excessive and unstoppable. While PrP-res,
a truncated amyloid form of the host protein, can trap infectious
particles in its aggregate matrix, and limit their release, the
continued production of enormous levels of PrP-res after the FU-
CJD agent is cleared has major ramifications for other
neurodegenerative diseases, including Alzheimer’s Disease (AD).
In AD the initiating cause of amyloid formation remains largely
unknown. AD pathology is likely to be initiated by various types of
cumulative insults, including toxins, physical stresses, and
infectious environmental agents. Alzheimer’s brain samples have
never shown reproducible transmissibility, unlike CJD [26].
However, that does not rule out an infectious origin for at least
a subset of AD cases. The above data show that even after an
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innate immune response that is inappropriate. Indeed, we
previously noted that past viral infections, as in von Economo’s
encephalitis (the ‘‘1918’’ influenza pandemic) represent ‘‘hit and
run’’ viruses that apparently disappear clinically, but nevertheless
can initiate or prime potential protein aggregation and misfolding
diseases in older age; in addition, apparently innocuous viral
sequences present in human brains (as the JC papova virus and
paramyxoviruses) may also trigger or prime abnormal protein
aggregates [27]. The original realization of post-encephalitic
Parkinson’s disease was based on typical viral induced glial
nodules in the substantia nigra of brains of people dying acutely
during the pandemic, with survivors developing post-encephalitic
tau positive neurofibrillary tangles (NFT) that are also present in
AD, in traumatic dementia pugilistica, and in subacute persistent
measles infections (subacute sclerosing pan-encephalitis). Post-
encephalitic changes, as classic pre-senile AD and TSEs, also
entail profound premature neuronal dropout. We propose that
past and ‘‘cured’’ viral infections, some of which may appear to be
innocuous, can also lead to a progressive cascade of amyloid
changes in membrane proteins such as PrP and APP (the precursor
of AD amyloid) that originate as part of an innate protective
response against environmental pathogens. In terms of public
health, a greater concentration on environmental insults could
lead to more effective preventive initiatives in a broad population.
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